184 related articles for article (PubMed ID: 26744310)
21. Purification and genetic characterisation of the novel bacteriocin LS2 produced by the human oral strain Lactobacillus salivarius BGHO1.
Busarcevic M; Dalgalarrondo M
Int J Antimicrob Agents; 2012 Aug; 40(2):127-34. PubMed ID: 22739096
[TBL] [Abstract][Full Text] [Related]
22. Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18.
Heng NC; Haji-Ishak NS; Kalyan A; Wong AY; Lovric M; Bridson JM; Artamonova J; Stanton JA; Wescombe PA; Burton JP; Cullinan MP; Tagg JR
J Bacteriol; 2011 Nov; 193(22):6402-3. PubMed ID: 22038965
[TBL] [Abstract][Full Text] [Related]
23. Effect of a bacteriocin-producing
Lawrence GW; McCarthy N; Walsh CJ; Kunyoshi TM; Lawton EM; O'Connor PM; Begley M; Cotter PD; Guinane CM
Gut Microbes; 2022; 14(1):2100203. PubMed ID: 35877697
[TBL] [Abstract][Full Text] [Related]
24. Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study.
Di Pierro F; Zanvit A; Nobili P; Risso P; Fornaini C
Clin Cosmet Investig Dent; 2015; 7():107-13. PubMed ID: 26491371
[TBL] [Abstract][Full Text] [Related]
25. The group I strain of Streptococcus mutans, UA140, produces both the lantibiotic mutacin I and a nonlantibiotic bacteriocin, mutacin IV.
Qi F; Chen P; Caufield PW
Appl Environ Microbiol; 2001 Jan; 67(1):15-21. PubMed ID: 11133423
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
Yoo HJ; Jwa SK; Kim DH; Ji YJ
Clin Exp Dent Res; 2020 Apr; 6(2):207-214. PubMed ID: 32250565
[TBL] [Abstract][Full Text] [Related]
27. Safety assessment of Streptococcus salivarius DB-B5 as a probiotic candidate for oral health.
Li X; Fields FR; Ho M; Marshall-Hudson A; Gross R; Casser ME; Naito M
Food Chem Toxicol; 2021 Jul; 153():112277. PubMed ID: 34004226
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a marine-derived dextranase and its application to the prevention of dental caries.
Jiao YL; Wang SJ; Lv MS; Jiao BH; Li WJ; Fang YW; Liu S
J Ind Microbiol Biotechnol; 2014 Jan; 41(1):17-26. PubMed ID: 24197466
[TBL] [Abstract][Full Text] [Related]
29. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.
Wescombe PA; Heng NC; Burton JP; Chilcott CN; Tagg JR
Future Microbiol; 2009 Sep; 4(7):819-35. PubMed ID: 19722837
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation.
Wu CC; Lin CT; Wu CY; Peng WS; Lee MJ; Tsai YC
Mol Oral Microbiol; 2015 Feb; 30(1):16-26. PubMed ID: 24961744
[TBL] [Abstract][Full Text] [Related]
31. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva.
Wescombe PA; Upton M; Dierksen KP; Ragland NL; Sivabalan S; Wirawan RE; Inglis MA; Moore CJ; Walker GV; Chilcott CN; Jenkinson HF; Tagg JR
Appl Environ Microbiol; 2006 Feb; 72(2):1459-66. PubMed ID: 16461700
[TBL] [Abstract][Full Text] [Related]
32. Diverse activity spectra of bacteriocin-like inhibitory substances having activity against mutans streptococci.
Balakrishnan M; Simmonds RS; Tagg JR
Caries Res; 2001; 35(1):75-80. PubMed ID: 11125201
[TBL] [Abstract][Full Text] [Related]
33. A Review of the Role of Probiotic Supplementation in Dental Caries.
Sivamaruthi BS; Kesika P; Chaiyasut C
Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1300-1309. PubMed ID: 32307660
[TBL] [Abstract][Full Text] [Related]
34. Isolation of a Streptococcus mutans strain producing a novel bacteriocin.
Hillman JD; Johnson KP; Yaphe BI
Infect Immun; 1984 Apr; 44(1):141-4. PubMed ID: 6706403
[TBL] [Abstract][Full Text] [Related]
35. Antagonistic effects of Streptococcus and Lactobacillus probiotics in pharyngeal biofilms.
Humphreys GJ; McBain AJ
Lett Appl Microbiol; 2019 Apr; 68(4):303-312. PubMed ID: 30776138
[TBL] [Abstract][Full Text] [Related]
36. Purification and certain properties of a bacteriocin from Streptococcus mutans.
Ikeda T; Iwanami T; Hirasawa M; Watanabe C; McGhee JR; Shiota T
Infect Immun; 1982 Mar; 35(3):861-8. PubMed ID: 7068219
[TBL] [Abstract][Full Text] [Related]
37. Cariogenicity of the probiotic bacterium Lactobacillus salivarius in rats.
Matsumoto M; Tsuji M; Sasaki H; Fujita K; Nomura R; Nakano K; Shintani S; Ooshima T
Caries Res; 2005; 39(6):479-83. PubMed ID: 16251792
[TBL] [Abstract][Full Text] [Related]
38. Engineered dextranase from Streptococcus mutans enhances the production of longer isomaltooligosaccharides.
Klahan P; Okuyama M; Jinnai K; Ma M; Kikuchi A; Kumagai Y; Tagami T; Kimura A
Biosci Biotechnol Biochem; 2018 Sep; 82(9):1480-1487. PubMed ID: 29806555
[TBL] [Abstract][Full Text] [Related]
39. Anti-
Juntarachot N; Sirilun S; Kantachote D; Sittiprapaporn P; Tongpong P; Peerajan S; Chaiyasut C
PeerJ; 2020; 8():e10165. PubMed ID: 33240599
[TBL] [Abstract][Full Text] [Related]
40. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.
Burton JP; Wescombe PA; Macklaim JM; Chai MH; Macdonald K; Hale JD; Tagg J; Reid G; Gloor GB; Cadieux PA
PLoS One; 2013; 8(6):e65991. PubMed ID: 23785463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]